Cargando…

Viremia Trajectories of HIV in HIV-Positive Women in the United States, 1994-2017

IMPORTANCE: Viral suppression of HIV is an important treatment goal to decrease morbidity, mortality, and risk of transmission to others. OBJECTIVE: To characterize longitudinal HIV viral load outcomes among women enrolled in the Women’s Interagency HIV Study (WIHS). DESIGN, SETTING, AND PARTICIPANT...

Descripción completa

Detalles Bibliográficos
Autores principales: Kassaye, Seble G., Wang, Cuiwei, Ocampo, Joanne Michelle F., Wilson, Tracey E., Anastos, Kathryn, Cohen, Mardge, Greenblatt, Ruth M., Fischl, Margaret A., Otofukun, Igho, Adimora, Adaora, Kempf, Mirjam-Colette, Sharp, Gerald B., Young, Mary, Plankey, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537820/
https://www.ncbi.nlm.nih.gov/pubmed/31099865
http://dx.doi.org/10.1001/jamanetworkopen.2019.3822
_version_ 1783422088690794496
author Kassaye, Seble G.
Wang, Cuiwei
Ocampo, Joanne Michelle F.
Wilson, Tracey E.
Anastos, Kathryn
Cohen, Mardge
Greenblatt, Ruth M.
Fischl, Margaret A.
Otofukun, Igho
Adimora, Adaora
Kempf, Mirjam-Colette
Sharp, Gerald B.
Young, Mary
Plankey, Michael
author_facet Kassaye, Seble G.
Wang, Cuiwei
Ocampo, Joanne Michelle F.
Wilson, Tracey E.
Anastos, Kathryn
Cohen, Mardge
Greenblatt, Ruth M.
Fischl, Margaret A.
Otofukun, Igho
Adimora, Adaora
Kempf, Mirjam-Colette
Sharp, Gerald B.
Young, Mary
Plankey, Michael
author_sort Kassaye, Seble G.
collection PubMed
description IMPORTANCE: Viral suppression of HIV is an important treatment goal to decrease morbidity, mortality, and risk of transmission to others. OBJECTIVE: To characterize longitudinal HIV viral load outcomes among women enrolled in the Women’s Interagency HIV Study (WIHS). DESIGN, SETTING, AND PARTICIPANTS: A prospective cohort study of HIV-positive women with semiannual study visits and a minimum of 5 follow-up visits was conducted from 1994 to 2017. The WIHS sites included in this analysis are in Brooklyn and Bronx, New York; Chicago, Illinois; San Francisco, California; and Washington, DC. MAIN OUTCOMES AND MEASURES: Women were categorized into groups based on their probability of achieving viral load suppression below 200 copies/mL using logistic trajectory modeling. Multinomial regression analysis was used to identify factors associated with placement in the group with the highest probability of viremia. RESULTS: At baseline, the mean (SD) age of the 1989 women was 36.9 (8.0) years, mean CD4(+) T-lymphocyte count was 467/mm(3), median (interquartile range) HIV RNA was 6200.0 (384.5-41 678.0) copies/mL, and 1305 women (65.6%) were African American. Three trajectory groups were identified with low (568 [28.6%]), intermediate (784 [39.4%]), and high (637 [32.0%]) probability of viremia above 200 copies/mL. The mean (SD) cumulative years of viral suppression were 18.7 (4.0) years, 12.2 (3.1) years, and 5.8 (2.9) years in the respective groups. Factors associated with high probability of viremia included younger age (odds ratio [OR]. 0.99; 95% CI, 0.98-0.99; P = .03), African American race (odds ratio [OR], 2.43; 95% CI, 1.75-3.37), P < .001), Hispanic race/ethnicity (OR, 1.50; 95% CI, 1.03-2.19; P = .04), increased levels of depressive symptoms (OR, 1.17; 95% CI, 1.01-1.36; P = .03), drug use (OR, 1.23; 95% CI, 1.01-1.51; P = .04), lower CD4+ T-lymphocyte counts (OR, 95% CI, 0.82; 0.80-0.85; P < .001), and unstable housing (OR, 1.25, 95% CI, 1.03-1.50; P = .02). Between 2015 and 2017, 71.2% of women demonstrated sustained viral suppression: 89.6% (310 of 346) of those with low viremia, 83.4% (346 of 415) with intermediate, and 35.2% (112 of 318) with high probability of viremia. CONCLUSIONS AND RELEVANCE: This longitudinal approach suggested that the probability of viremia decreased substantially over time for most participants, including among women with earlier histories of incomplete viral suppression. The findings from this study suggest that continued efforts are needed to address mental health, social, behavioral and structural factors that were identified as associated with high probability of HIV viremia over time.
format Online
Article
Text
id pubmed-6537820
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-65378202019-06-12 Viremia Trajectories of HIV in HIV-Positive Women in the United States, 1994-2017 Kassaye, Seble G. Wang, Cuiwei Ocampo, Joanne Michelle F. Wilson, Tracey E. Anastos, Kathryn Cohen, Mardge Greenblatt, Ruth M. Fischl, Margaret A. Otofukun, Igho Adimora, Adaora Kempf, Mirjam-Colette Sharp, Gerald B. Young, Mary Plankey, Michael JAMA Netw Open Original Investigation IMPORTANCE: Viral suppression of HIV is an important treatment goal to decrease morbidity, mortality, and risk of transmission to others. OBJECTIVE: To characterize longitudinal HIV viral load outcomes among women enrolled in the Women’s Interagency HIV Study (WIHS). DESIGN, SETTING, AND PARTICIPANTS: A prospective cohort study of HIV-positive women with semiannual study visits and a minimum of 5 follow-up visits was conducted from 1994 to 2017. The WIHS sites included in this analysis are in Brooklyn and Bronx, New York; Chicago, Illinois; San Francisco, California; and Washington, DC. MAIN OUTCOMES AND MEASURES: Women were categorized into groups based on their probability of achieving viral load suppression below 200 copies/mL using logistic trajectory modeling. Multinomial regression analysis was used to identify factors associated with placement in the group with the highest probability of viremia. RESULTS: At baseline, the mean (SD) age of the 1989 women was 36.9 (8.0) years, mean CD4(+) T-lymphocyte count was 467/mm(3), median (interquartile range) HIV RNA was 6200.0 (384.5-41 678.0) copies/mL, and 1305 women (65.6%) were African American. Three trajectory groups were identified with low (568 [28.6%]), intermediate (784 [39.4%]), and high (637 [32.0%]) probability of viremia above 200 copies/mL. The mean (SD) cumulative years of viral suppression were 18.7 (4.0) years, 12.2 (3.1) years, and 5.8 (2.9) years in the respective groups. Factors associated with high probability of viremia included younger age (odds ratio [OR]. 0.99; 95% CI, 0.98-0.99; P = .03), African American race (odds ratio [OR], 2.43; 95% CI, 1.75-3.37), P < .001), Hispanic race/ethnicity (OR, 1.50; 95% CI, 1.03-2.19; P = .04), increased levels of depressive symptoms (OR, 1.17; 95% CI, 1.01-1.36; P = .03), drug use (OR, 1.23; 95% CI, 1.01-1.51; P = .04), lower CD4+ T-lymphocyte counts (OR, 95% CI, 0.82; 0.80-0.85; P < .001), and unstable housing (OR, 1.25, 95% CI, 1.03-1.50; P = .02). Between 2015 and 2017, 71.2% of women demonstrated sustained viral suppression: 89.6% (310 of 346) of those with low viremia, 83.4% (346 of 415) with intermediate, and 35.2% (112 of 318) with high probability of viremia. CONCLUSIONS AND RELEVANCE: This longitudinal approach suggested that the probability of viremia decreased substantially over time for most participants, including among women with earlier histories of incomplete viral suppression. The findings from this study suggest that continued efforts are needed to address mental health, social, behavioral and structural factors that were identified as associated with high probability of HIV viremia over time. American Medical Association 2019-05-17 /pmc/articles/PMC6537820/ /pubmed/31099865 http://dx.doi.org/10.1001/jamanetworkopen.2019.3822 Text en Copyright 2019 Kassaye SG et al. JAMA Network Open. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Kassaye, Seble G.
Wang, Cuiwei
Ocampo, Joanne Michelle F.
Wilson, Tracey E.
Anastos, Kathryn
Cohen, Mardge
Greenblatt, Ruth M.
Fischl, Margaret A.
Otofukun, Igho
Adimora, Adaora
Kempf, Mirjam-Colette
Sharp, Gerald B.
Young, Mary
Plankey, Michael
Viremia Trajectories of HIV in HIV-Positive Women in the United States, 1994-2017
title Viremia Trajectories of HIV in HIV-Positive Women in the United States, 1994-2017
title_full Viremia Trajectories of HIV in HIV-Positive Women in the United States, 1994-2017
title_fullStr Viremia Trajectories of HIV in HIV-Positive Women in the United States, 1994-2017
title_full_unstemmed Viremia Trajectories of HIV in HIV-Positive Women in the United States, 1994-2017
title_short Viremia Trajectories of HIV in HIV-Positive Women in the United States, 1994-2017
title_sort viremia trajectories of hiv in hiv-positive women in the united states, 1994-2017
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537820/
https://www.ncbi.nlm.nih.gov/pubmed/31099865
http://dx.doi.org/10.1001/jamanetworkopen.2019.3822
work_keys_str_mv AT kassayesebleg viremiatrajectoriesofhivinhivpositivewomenintheunitedstates19942017
AT wangcuiwei viremiatrajectoriesofhivinhivpositivewomenintheunitedstates19942017
AT ocampojoannemichellef viremiatrajectoriesofhivinhivpositivewomenintheunitedstates19942017
AT wilsontraceye viremiatrajectoriesofhivinhivpositivewomenintheunitedstates19942017
AT anastoskathryn viremiatrajectoriesofhivinhivpositivewomenintheunitedstates19942017
AT cohenmardge viremiatrajectoriesofhivinhivpositivewomenintheunitedstates19942017
AT greenblattruthm viremiatrajectoriesofhivinhivpositivewomenintheunitedstates19942017
AT fischlmargareta viremiatrajectoriesofhivinhivpositivewomenintheunitedstates19942017
AT otofukunigho viremiatrajectoriesofhivinhivpositivewomenintheunitedstates19942017
AT adimoraadaora viremiatrajectoriesofhivinhivpositivewomenintheunitedstates19942017
AT kempfmirjamcolette viremiatrajectoriesofhivinhivpositivewomenintheunitedstates19942017
AT sharpgeraldb viremiatrajectoriesofhivinhivpositivewomenintheunitedstates19942017
AT youngmary viremiatrajectoriesofhivinhivpositivewomenintheunitedstates19942017
AT plankeymichael viremiatrajectoriesofhivinhivpositivewomenintheunitedstates19942017